Catalyst Pharmaceuticals, Inc.

WEDGE CAPITAL MANAGEMENT L L P/NC CPRX

Report date

9/30/2025

Quarter

2025 Q3

Filed

10/10/2025

Shares

145,168

Value ($000)

2,860

Weight

0.0%

2020 Q2 - 2025 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	10/10/2025	2,860	0.0%	145,168	9/30/2025
2023 Q1	4/11/2023	248	0.0%	14,978	3/31/2023
2022 Q4	1/17/2023	257	0.0%	13,803	12/31/2022
2022 Q3	10/13/2022	129	0.0%	10,020	9/30/2022
2022 Q2	7/11/2022	117	0.0%	16,716	6/30/2022
2022 Q1	4/12/2022	132	0.0%	15,864	3/31/2022
2021 Q4	1/24/2022	144	0.0%	21,235	12/31/2021
2021 Q3	10/14/2021	125	0.0%	23,580	9/30/2021
2021 Q2	7/14/2021	100	0.0%	17,466	6/30/2021
2021 Q1	4/12/2021	129	0.0%	27,963	3/31/2021
2020 Q4	1/8/2021	631	0.0%	188,936	12/31/2020
2020 Q3	10/8/2020	369	0.0%	124,201	9/30/2020
2020 Q2	7/10/2020	585	0.0%	126,674	6/30/2020